Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Crescent Biopharma Inc banner

Crescent Biopharma Inc
F:C68

Watchlist Manager
Crescent Biopharma Inc Logo
Crescent Biopharma Inc
F:C68
Watchlist
Price: 14.6 EUR Market Closed
Market Cap: €202.8m
Write Note Create Alert Ask AI

Wall St Price Targets

C68 Price Targets Summary
Crescent Biopharma Inc

Wall Street analysts forecast C68 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for C68 is 18.09 EUR with a low forecast of 15.6 EUR and a high forecast of 21.03 EUR.

C68 Lowest Forecast
15.6 EUR
7% Upside
C68 Average Forecast
18.09 EUR
24% Upside
C68 Highest Forecast
21.03 EUR
44% Upside
Lowest Forecast
Price Target
15.6 EUR
7% Upside
Average Forecast
Price Target
18.09 EUR
24% Upside
Highest Forecast
Price Target
21.03 EUR
44% Upside
Crescent Biopharma Inc Competitors:
Price Targets
EOLS
Evolus Inc
118% Upside
ZEAL
Zealand Pharma A/S
76% Upside
NWSA
News Corp
30% Upside
A
ANY
ANY Biztonsagi Nyomda Nyrt
8% Upside
EOLS
Evolus Inc
118% Upside
ZEAL
Zealand Pharma A/S
76% Upside
NWSA
News Corp
30% Upside
A
ANY
ANY Biztonsagi Nyomda Nyrt
8% Upside
RLMD
Relmada Therapeutics Inc
110% Upside

Revenue
Forecast

-3% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-3% / Year
Past Growth
77% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 77%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Continue C68 Research

Summary
C68 intrinsic value, competitors valuation, and company profile.
DCF Valuation
C68 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
C68 stock valuation using valuation multiples.
Wall St Estimates
C68 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
C68 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is C68's stock price target?
Price Target
18.09 EUR

According to Wall Street analysts, the average 1-year price target for C68 is 18.09 EUR with a low forecast of 15.6 EUR and a high forecast of 21.03 EUR.

What is the Revenue forecast for Crescent Biopharma Inc?
Projected CAGR
77%

Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 77%.

Back to Top
ALPHA SPREAD
Follow us
Join 347,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett